Zhejiang Haisen Pharmaceutical Co., Ltd. (SHE:001367)
24.84
-0.34 (-1.35%)
At close: Sep 9, 2025
SHE:001367 Revenue
Zhejiang Haisen Pharmaceutical had revenue of 123.61M CNY in the quarter ending June 30, 2025, with 30.33% growth. This brings the company's revenue in the last twelve months to 502.96M, up 21.28% year-over-year. In the year 2024, Zhejiang Haisen Pharmaceutical had annual revenue of 471.51M with 18.63% growth.
Revenue (ttm)
502.96M
Revenue Growth
+21.28%
P/S Ratio
7.43
Revenue / Employee
758.61K
Employees
663
Market Cap
3.74B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 471.51M | 74.06M | 18.63% |
Dec 31, 2023 | 397.45M | -25.32M | -5.99% |
Jan 1, 2023 | 422.78M | 33.79M | 8.69% |
Dec 31, 2021 | 388.98M | 104.18M | 36.58% |
Dec 31, 2020 | 284.80M | 18.47M | 6.94% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 30.15B |
WuXi AppTec | 41.90B |
Shenzhen Mindray Bio-Medical Electronics | 32.94B |
Sichuan Biokin Pharmaceutical | 441.19M |
Shanghai United Imaging Healthcare | 10.98B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.52B |
Aier Eye Hospital Group | 21.94B |
Yunnan Baiyao Group Co.,Ltd | 40.84B |